TRP Channel Cooperation for Nociception: Therapeutic Opportunities
Related Experiment Video
Updated: Dec 7, 2025
Dorien Bamps1, Joris Vriens2, Jan de Hoon1
1Center for Clinical Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
Abstract:
Chronic pain treatment remains a sore challenge, and in our aging society, the number of patients reporting inadequate pain relief continues to grow. Current treatment options all have their drawbacks, including limited efficacy and the propensity of abuse and addiction; the latter is exemplified by the ongoing opioid crisis. Extensive research in the last few decades has focused on mechanisms underlying chronic pain states, thereby producing attractive opportunities for novel, effective and safe pharmaceutical interventions. Members of the transient receptor potential (TRP) ion channel family represent innovative targets to tackle pain sensation at the root. Three TRP channels, TRPV1, TRPM3, and TRPA1, are of particular interest, as they were identified as sensors of chemical- and heat-induced pain in nociceptor neurons. This review summarizes the knowledge regarding TRP channel-based pain therapies, including the bumpy road of the clinical development of TRPV1 antagonists, the current status of TRPA1 antagonists, and the future potential of targeting TRPM3.
Insights
Transient Receptor Potential (TRP) channels offer novel targets for safe and effective chronic pain therapies. This review examines TRPV1, TRPM3, and TRPA1 channel antagonists for pain relief.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Chronic pain affects an aging population, with current treatments lacking efficacy and posing addiction risks, as seen in the opioid crisis.
- Transient Receptor Potential (TRP) ion channels are key players in pain sensation, offering new therapeutic targets.
- TRP channels TRPV1, TRPM3, and TRPA1 are critical sensors of chemical and heat stimuli in pain pathways.
Purpose of the Study:
- To review the current landscape of TRP channel-based pain therapies.
- To discuss the clinical development challenges and status of TRPV1 and TRPA1 antagonists.
- To explore the future therapeutic potential of targeting TRPM3 for chronic pain.
Main Methods:
- Literature review of preclinical and clinical studies on TRP channel modulators for pain.
- Analysis of the mechanisms of action for TRPV1, TRPM3, and TRPA1 in pain signaling.
- Evaluation of the efficacy and safety profiles of TRP channel antagonists in development.
Main Results:
- TRPV1 antagonists have faced significant hurdles in clinical development.
- TRPA1 antagonists are currently under investigation with varying degrees of success.
- TRPM3 presents a promising, yet less explored, target for novel pain therapeutics.
Conclusions:
- TRP channels represent a significant frontier in developing safer and more effective chronic pain treatments.
- Targeting specific TRP channels like TRPM3 holds potential for future pharmaceutical interventions.
- Continued research into TRP channel pharmacology is crucial for addressing unmet needs in pain management.
Related Concept Videos
Nociception
Analgesia and Pain Management
Thermosensation
Opioid Receptors: Overview
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....


